- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Middle East Pharmaceutical (4016)
Middle East Pharmaceutical stock price live, this page displays TADAWUL 4016 stock exchange data. View the 4016 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Middle East Pharmaceutical real time stock price chart below.
What Is the Middle East Pharmaceutical Stock Price Today?
The Middle East Pharmaceutical stock price today is 122.30.
What Is the Stock Symbol for Middle East Pharmaceutical?
The stock symbol for Middle East Pharmaceutical is "4016."
What Stock Exchange Does Middle East Pharmaceutical Trade On?
Middle East Pharmaceutical is listed and trades on the Saudi Arabia stock exchange.
Is Middle East Pharmaceutical a Good Stock to Buy?
Determining whether Middle East Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4016 quote. (ISIN: SA160G51UO10)
What Is the Middle East Pharmaceutical Stock Price Today?
The Middle East Pharmaceutical stock price today is 122.30.
What Is the Stock Symbol for Middle East Pharmaceutical?
The stock symbol for Middle East Pharmaceutical is "4016."
What Stock Exchange Does Middle East Pharmaceutical Trade On?
Middle East Pharmaceutical is listed and trades on the Saudi Arabia stock exchange.
Is Middle East Pharmaceutical a Good Stock to Buy?
Determining whether Middle East Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4016 quote. (ISIN: SA160G51UO10)
Saudi Arabia
Currency in SAR
122.30
-0.50(-0.41%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
121.40
123.00
52 wk Range
107.00
144.60
4016 Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
4016 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
121.40123.00
52 wk Range
107.00144.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4016 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
124.40
Upside
+1.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Middle East Pharmaceutical Company Profile
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic medicines and preparations, including sexual system drugs, diabetes, cardiovascular drugs, anti-infective drugs, anti-parasitic drugs, pain relievers, antiseptics, and women’s and men’s health drugs in the form of creams, rolls, ointments, syrups, masks, tonics, lotions, capsules, gels, hand sanitizers, mouthwashes, soaps, solutions, sprays, scrubs, topical solutions, and tablets. The company also provides contract manufacturing services. In addition, it specializes in cosmetic, health products and nutritional supplements. The company also exports its products. Middle East Pharmaceutical Industries Company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Compare 4016 to Peers and Sector
Metrics to compare | 4016 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4016PeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.3x | 13.2x | −0.5x | |
PEG Ratio | 1.46 | 0.05 | 0.00 | |
Price/Book | 6.3x | 1.5x | 2.6x | |
Price / LTM Sales | 5.9x | 1.5x | 3.2x | |
Upside (Analyst Target) | 1.3% | 4.6% | 45.4% | |
Fair Value Upside | Unlock | 22.4% | 6.9% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 124.40
(+1.72% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
0.97 / --
Revenue / Forecast
97.00M / --
People Also Watch
FAQ
What Is the Middle East Pharmaceutical (4016) Stock Price Today?
The Middle East Pharmaceutical stock price today is 122.30
What Stock Exchange Does Middle East Pharmaceutical Trade On?
Middle East Pharmaceutical is listed and trades on the Saudi Arabia Stock Exchange stock exchange.
What Is the Stock Symbol for Middle East Pharmaceutical?
The stock symbol for Middle East Pharmaceutical is "4016."
Does Middle East Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Middle East Pharmaceutical dividend yield is 1.64%.
What Is the Middle East Pharmaceutical Market Cap?
As of today, Middle East Pharmaceutical market cap is 2.46B.
What Is Middle East Pharmaceutical's Earnings Per Share (TTM)?
The Middle East Pharmaceutical EPS (TTM) is 4.49.
When Is the Next Middle East Pharmaceutical Earnings Date?
Middle East Pharmaceutical will release its next earnings report on 10 Aug 2025.
From a Technical Analysis Perspective, Is 4016 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Middle East Pharmaceutical Stock Split?
Middle East Pharmaceutical has split 0 times.
How Many Employees Does Middle East Pharmaceutical Have?
Middle East Pharmaceutical has 632 employees.
What is the current trading status of Middle East Pharmaceutical (4016)?
As of 13 July 2025, Middle East Pharmaceutical (4016) is trading at a price of 122.30, with a previous close of 122.80. The stock has fluctuated within a day range of 121.40 to 123.00, while its 52-week range spans from 107.00 to 144.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.